Download Department of Clinical Oncology

Consultant Clinical or Medical Oncologist:
Lower GI Cancer
Christie Hospital NHS Foundation Trust
JOB DESCRIPTION
Contents
Page
A)
Christie Hospital NHS Foundation Trust
2
B)
University of Manchester: Cancer Studies
2
C)
Department of Clinical Oncology
3
D)
CRUK Department of Medical Oncology
4
E)
Associated Departments
5
F)
Gastro–Intestinal Disease Orientated Group
7
G)
Proposed Appointment
7
H)
Indicative Timetable
9
I)
Duties of the Post
9
J)
Person Specification
11
K)
Informal Visits
12
Appendix 1: Clinical Oncology Consultants
13
Appendix 2: Medical Oncology Consultants
14
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
1
A)
Christie Hospital NHS Foundation Trust
Situated in a pleasant suburb, some 3 miles from Manchester city centre, the Christie
Hospital and Holt Radium Institute was founded in 1932 and has grown to be the largest
Cancer Hospital in the UK and one of the largest Cancer Centres in Europe covering a
large population in North West England. In addition to the Christie Hospital itself, the
Trust also comprises the North Western Medical Physics Department, one of the largest
of its kind in the UK, and the Paterson Institute for Cancer Research, funded by Cancer
Research UK. The Hospital is a designated teaching hospital of the University of
Manchester and is a focal point of the Greater Manchester and Cheshire Cancer
Network. All cancer-related specialties are fully operational and over 12,000 new patients
with cancer are seen each year. The Christie site is the focal point of the recently
established Manchester Cancer Research Centre.
The Christie Hospital is composed of three clinical management divisions
Networked Services Division – Director Dr Wendy Makin – includes the Departments of
Medical Oncology, Clinical Oncology, Palliative Care, Paediatric and Adolescent
Oncology
Cancer Centre Services – Director Miss Sarah O’Dwyer - Surgery, Anaesthetics,
Haematology, HDU, Endocrinology
Clinical Support Services – Director Dr Jeremy Lawrance - Radiology, Pathology.
Other support services are provided by the Divisions of Finance, Nursing & Operations
and Estates and Facilities.
Both the Departments of Medical Oncology (Director: Dr Michael Leahy) and Clinical
Oncology (Director: Dr Nick Slevin), have international reputations for their clinical work.
All consultants are site specialised and common treatment policies are developed
through the multi-disciplinary Disease Oriented Groups (DOGs). Links to the cancer
units are maintained through a number of peripheral and outreach clinics across the
network. There are plans for the Christie to develop satellite centre’s at the Pennine
Acute Trust and at Salford Royal Hospital Trust so that ambulatory can be can be
delivered more locally.
The Christie Hospital NHS Foundation Trust is committed to cancer research and there
was a successful Centenary Appeal that raised £25m for development of work at the
Christie. Amongst other projects it is planned that £1m will go to an innovative treatment
centre, £3m to the development of a Molecular Diagnostics Unit, which has already
commenced, and £3.5m for the development of a Gene Therapy Centre. These, along
with other developments, will further enhance the research standing of the Trust.
The present Executive Directors of the Trust are:
Caroline Shaw
Ian Moston
Dr Ron Stout
Dr Chris Harrison
Alison Norman
Roger Spencer
B)
-
Chief Executive
Executive Director of Finance & Performance
Medical Executive Director (Internal)
Medical Director (External)
Executive Director of Nursing & Governance
Chief Operating Officer
University of Manchester: Cancer Studies
Cancer Studies at the University of Manchester (Group Leader: Professor A Freemont)
comprises a number of research groupings including the CRUK Department of Medical
Oncology, Cancer Epidemiology and the Academic Department of Radiation Oncology.
There are close links with the Paterson Institute for Cancer Research and a number of
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
2
the Institute’s senior staff have honorary University posts within Cancer Studies which
was rated 5* in the 2001 Research Assessment Exercise (RAE). The major grouping
within Cancer Studies is the CRUK Department of Medical Oncology that is one of the
largest in the country. The department has laboratories located within the Paterson
Institute and annual grant support of about £2m per annum from the CRUK, the Kay
Kendall Leukaemia Fund, AICR, BBSRC, EU and others.
There is a wide range of clinical and laboratory research within the Department. The
appointment of Professor Hawkins as CRUK Professor of Medical Oncology has led to
an expansion of translational research activity particularly in the field of gene and
immunotherapy, with a focus on gastrointestinal cancer.
Overall, the areas of laboratory research within Medical Oncology comprise: growth
factors and glycobiology (Professor J Gallagher, Professor G Jayson), breast biology
(Professor A Howell and Dr Rob Clark), immunology and cancer vaccines (Professor R
Hawkins closely linked with Professor P Stern), gene therapy (Professor R Hawkins and
Dr D Gilham). The Hospital has a Statistics Department, directed by Mr. R Swindell,
which offers support to clinicians involved in clinical studies and trials.
In addition to the above links there are close links with groups in the Paterson Institute.
The Paterson is a major Cancer Research UK Institute with £8M per year grant support
and a broad range of basic and translational research. The research groups include:
Bioinformatics - Crispin Miller
Carcinogenesis -Geoff Margison
Cell Division - Iain Hagan
Cell Regulation - Nic Jones
Cellular and Molecular Pharmacology - Caroline Dive
Cell Signaling - Angeliki Malliri
Functional Genomics and Cell Cycle Regulation - Karim Labib
Immunology - Peter L. Stern
Radiochemical Targeting and Imaging - Jamal Zweit
Stem Cell Biology - Georges Lacaud
Stem Cell and Haematopoiesis - Valerie Kouskoff
Structural Cell Biology - Terry Allen
The institute has excellent central services including molecular biology (sequencing, realtime PCR, Affymetrix Micro array), FACs analysis and sorting, image analysis and
pharmacology.
Pat Price (Professor of Radiation Oncology) is developing a major new Molecular
Imaging Centre for translational studies which will provide state-of-the-art PET scanning
facilities. The design of this £8m building is the most advanced centre of its kind
internationally. Together with the large Oncology practice, extensive CRUK Phase I
activities and the Paterson Institute it will facilitate mechanistic trials of novel agents.
C)
Department of Clinical Oncology
The Department of Clinical Oncology presently provides a service to Greater Manchester
and Cheshire, and parts of Lancashire, through regular clinics (mainly weekly), staffed by
its consultants (see appendix 1). The population of the Hospital’s catchment area is
approximately 3.2 million. A total of 11,000 new patients with cancer were seen by the
hospital and associated clinics in 2006. In 2006, 8,000 patients were treated with
radiotherapy. We have close links with the Rosemere Cancer Centre at Preston.
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
3
The Radiotherapy Department has eleven service linear accelerators, a research linac
suite (Wade Centre), and a Pantak superficial x-ray therapy unit. Two of the linacs are
Elekta Synergy linacs with facilities for image guided radiotherapy. There are three
simulators, 2 with CT attachments, one with cone beam imaging and an application for a
CT-Sim is ongoing. There is an ADAC Pinnacle computerised treatment planning
system. IMRT for prostate cancer has been in use for several years.
There are plans to develop Satellite Radiotherapy facilities over the next 3 years away
from the Withington site. These are most likely in the first place to be built at a site in the
north of the conurbation. The successful candidate would not be expected to take a role
in supervising treatments at this satellite unit though additional units are planned in other
areas of the Network.
There is a purpose built, Radiotherapy Theatre housing a high dose rate microselectron.
Adjacent to one ward is a low dose rate Selectron remote afterloading suite for
Gynaecological patients.
There is a fully equipped Mould Room.
Facilities are present for interstitial therapy (including prostate brachytherapy) and
manually afterloaded brachytherapy. In 2006 approximately 200 permanent Iodine 125
seed implants were conducted. A business case to develop HDR brachytherapy is in
place and treatment of patients will begin in 2007/08.
The Isotope Department provides facilities for the therapeutic use of I 131, P 32, Sr 89
and Samarium. There are three rooms for the management of patients being treated
with unsealed Isotopes.
There is a large group of therapeutic radiographers. The hospital is a teaching unit of the
University of Liverpool, School of Therapy Radiography.
The North West medical physics group is based at the Christie, is directed by Professor
Peter Williams and supports the Radiotherapy Department. IMRT has been developed
for prostate cancer, breast cancer, head and neck cancer, and will be introduced in other
tumour sites in due course.
Clinical Staff
The medical staff establishment provides for twenty-seven Clinical Oncology
Consultants, (see appendix 1) 3 full time academics and fifteen Specialist Registrars in
Clinical Oncology. There is a junior doctor team at F2 level, working jointly with medical
oncology and haematology, within the Division of Networked Services.
D)
Department of Medical Oncology
The Department of Medical Oncology is now one of the largest departments of cancer
medicine in the UK. Dr Michael Leahy is Director of Medical Oncology and the major
remit of the department is to develop improved methods for cancer patient management.
There are both clinical and laboratory scientific research components that are closely
integrated with clinical research and service work.
The Department is based at the Christie Cancer Centre (Christie Hospital and Paterson
Institute for Cancer Research) with a Breast Cancer Unit at Wythenshawe / Withington
Hospital (University Hospitals of South Manchester) and a Thoracic Oncology Unit at
Wythenshawe Hospital (Cardiothoracic Centre). More than 2,500 new cancer patients
are seen each year by staff in the Department of Medical Oncology.
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
4
The Department has links with Preston Oncology Centre and with the Department of
Medical Oncology at Lancaster Royal Infirmary, which is included as part of the Medical
Oncology SpR rotation (total 17 NTN’s). Consultant Medical Oncologists at Preston,
Lancaster and Blackpool form part of the extended Department and have many common
protocols with Manchester.
Clinical Staff
There are nineteen consultants in the department of Medical Oncology (see appendix 2).
There are at present eleven Specialist Registrars, six SHO level posts. Eight Clinical
Research Fellows also participate in clinical activities, in addition to their laboratory
research. There will be further posts developed as the Foundation programme rolls out.
E)
Associated Departments
Haematological Oncology
Dr James Cavet, Dr Effie Liakopoulou , Dr Adrian Bloor and Dr Mike Dennis run a major
transplant unit with 18 dedicated beds. Appointment of a Professor and Senior Lecturer
are planned shortly.
Ward facilities
1.
2.
3.
4.
5.
6.
General medical oncology wards – 40 inpatient beds available on modern wards
with excellent routine facilities.
16 inpatient chemotherapy beds shared with Clinical Oncology. Used for shorter
stay chemotherapy treatments, these beds are not normally open at weekends.
The Adult Leukaemia Unit (ALU), with 18 beds available for the care of adult
patients with haematological malignancy and lymphoma requiring myeloablative
therapy with haemopoietic rescue.
Chemotherapy Day Wards (wards 3 and 5). Used for longer day case
chemotherapy treatments, with 9 inpatient beds available if necessary.
Eight bedded Critical Care Unit.
The Christie has a private patient facility (Nathan House) that has 18 rooms.
These are primarily for private patients but are made available to NHS patients if
the need arises
A wide range of cancers are managed in these ward facilities and practical training in all
aspects of cancer medicine is provided at SHO/SpR levels. Special facilities include two
cell separators for leukapheresis and plasmapheresis.
Outpatient facilities
Routine medical oncology clinics are held daily at the Christie Hospital for new patients
and follow up. There are specialised cancer site related collaborative clinics and routine
outpatient clinics. Several of the Consultants visit DGH’s within the Greater Manchester
and Cheshire Cancer Network to undertake clinics for new and follow-up patients. We
are currently reviewing our outpatient facilities, and the treatment and follow-up
appointments, with a view to moving some of the activity to Cancer Units in the network.
Specialist nurse facilities
Teams of specialist chemotherapy and research nurses work alongside the clinicians.
These nurses have special expertise and training in the administration of chemotherapy.
Specialist nurses are also trained to insert i.v. long lines, carry out bone marrow
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
5
aspiration/trephine procedures, operate the cell separators for leukapheresis and provide
psychological support and counselling.
Other departments
The Department of Histopathology provides a regional cancer service.
The Department of Diagnostic Radiology has two whole body spiral CAT scanners and
two MR scanners, in addition to standard radiological and radionucleide imaging
facilities. This department is currently undergoing major refurbishment, and will be recommissioned with new and more extensive equipment next year.
The Department of Psychological Medicine is involved in collaborative research projects
concerning psychological assessment and counselling in the context of clinical trials and
is responsible for staff training in aspects of psychological support.
Clinical and Laboratory Scientific Research
A wide range of clinical research studies are in progress. The breast, lung and GI
research groups are major contributors to national and international trials of new
treatments. These include Phase I/II and III chemotherapy studies, combined surgery,
radiotherapy and chemotherapy studies and patient evaluation studies (staging
procedures, psychological assessment etc). A special interest is taken in the
development of new biological therapies particularly anti-angiogenic therapies (lead by
Professor Gordon Jayson) and gene/immunotherapies (lead by Professor Robert
Hawkins).
These link laboratory research in the Paterson Institute with early phase clinical trials.
The Derek Crowther Unit was opened in 2003 (lead clinician Dr Malcolm Ranson) and
provides excellent clinical research facilities for early phase clinical trials.
Excellent computer facilities are available within the Medical Oncology Directorate and
there is a close association with the Department of Medical Statistics. Data managers
are in post to help handle clinical and laboratory research data. Training is given in this
important aspect of clinical research.
Travel facilities
Support is available for participation in research meetings.
Administrative facilities
The post holder will have office accommodation with computer, intranet and internet
access at both sites. There will be secretarial support appointed to support the post.
F)
Gastro-intestinal Disease Orientated Group
The Gastrointestinal DOG also provides comprehensive treatment for GI Cancers and
has a broad ranging laboratory and clinical research portfolio. The DOG group covers
surgical and non-surgical oncology and the core members (and their primary clinical
interest) are:
Oncologists
Dr Paul Burt
–
Dr Corinne Finn
Prof. Robert Hawkins –
New Posts:
Oesophageal Radiotherapy
Oesophageal Radiotherapy
Renal/Oesophago-Gastric systemic therapy
Phase I trials of gene/immunotherapy
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
6
Dr Ed Levine
Dr Catherine McBain
Dr Vivek Misra
Dr Mark Saunders
–
–
–
–
Dr Juan Valle
–
Dr Greg Wilson
Dr Jurjees Hassan
Dr Saifee Mullamitha Dr Was Mansoor
Dr Fiona Thistlethwaite Surgeons
Miss Sarah O’Dwyer
Mr. David Sherlock
Mr. Ian Welch
Mr. Malcolm Wilson
G)
–
–
–
–
Colorectal/anal chemotherapy and radiotherapy
Colorectal chemotherapy and radiotherapy
Colorectal chemotherapy and radiotherapy
Colorectal/anal chemotherapy and radiotherapy, Gastric
Adjuvant Radiotherapy. Pseudomyxoma
Colorectal, cholangiocarcinoma, hepatocellular
carcinoma, pancreatic cancer neuroendocrine
Colorectal Chemotherapy
Colorectal Chemotherapy
Colorectal chemotherapy
Oesphago-Gastric Chemotherapy and Carcinoid
Oesphago-Gastric Chemotherapy and Gene
/Immunotherapy Research
Colorectal and pelvic malignancy
Hepatobiliary Surgery
Upper GI Surgery
Colorectal and pelvic malignancy
The proposed appointment
The Christie hospital gastrointestinal unit is referred approximately 1200 case per year of
which, about 700 are patients with colorectal cancer. We also have a particular interest
in rarer tumours such as anal cancer, neuroendocrine tumours and pseudomyxoma
peritonei. We work very closely as a gastrointestinal disease orientated group (GI DOG).
In total, there are already six medical oncology consultants and four clinical oncology
consultants who specialise in GI malignancies within the abdominal cavity. There are
also four lower GI surgeons and together we have a number of joint or parallel clinics
and multidisciplinary meetings (MDT). The colorectal and pancreatobiliary section of the
GI DOG has a separate research unit that holds six research nurses, four data
managers, a trials coordinator and clerk. They are essential for the coordination and
management of the vast array of clinical trials that we are involved with. We also have
two nurse clinicians and two GP clinical assistants that provide valuable help in the busy
Christie chemotherapy clinics. We have an active network that coordinates treatment
and provides guidelines for patients being managed in the Greater Manchester and
Cheshire region. Patients are regularly seen in peripheral units such as Wythenshaw and
Leighton Hospitals and simple therapies are often administered locally. The aim is to
increase the number of patient treated in these units and also to expand the number of
clinical trials available to them. All patients that require radiotherapy are treated within
the Christie Hospital.
The successful applicant will be based at Christie hospital but will have weekly sessions
at both Leighton and Wythenshaw Hospitals. At the former hospital, the post-holder will
be required to continue with the clinic and MDT sessions as well as setting up a
comprehensive GI chemotherapy service for patients in this region. At Wythenshaw, the
post-holder will be expected to collaborate with Dr Mark Saunders and continue to
provide a regular clinical session and MDT service at this hospital. The main aim
centrally will be to continue to expand the clinical trial service offered at the Christie.
There will also be adequate opportunity to collaborate with other investigators within the
Christie and also scientists within the Paterson Institute in other areas of GI research.
We expect the new appointment to manage a new referral case load of approximately
250 patients a year
Management/Audit
The appointee will play a full part in clinical audit as a member of the Christie Hospital
Medical Staff Committee.
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
7
Continuing Medical Education
The Trust supports the requirements for continuing medical education as laid down by
the appropriate Royal College and is committed to providing time and financial support
for these activities.
Proposed PA’s
As indicated, this is a new post and 10 PA’s will be offered (7.5 D Direct Clinical Activities
and 2.5 Supporting Professional Activities) The prospective candidates will need to
discuss their specific clinical interests with both Trusts. This Job Plan is indicative and
may evolve as oncology services across the network develop.
SERVICE
Location
Direct Clinical Care
Programmed Activity
Outpatient
clinics/MDTs
at
Wythenshawe/Leighton
Hospitals
Ward Rounds,
Christie Hospital
Radiotherapy
simulator,
computer planning at Christie
Hospital
Outpatient clinics at Christie
Hospital
3
Clinical trial activity
0.5 – 1
MDT / x-ray meetings at christie
0.5
0.5
1 - 1.5 (if clinical oncologist)
2.5
Supporting professional
2.5
Activities
(training, CPD, teaching, audit,
clinical governance, appraisal
and clinical management)
Total
10
(slight variations to cover possibility of CO or MO being appointed)
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
8
H)
Indicative Timetable
The following is the proposed timetable.
Monday
( Christie )
Tuesday
( Christie/Wyth )
Wednesday
(Christie)
Thursday
(Christ/Leightn)
Friday
(Christie)
8 am pelvic meet
(alt wks)
9 am to 1 pm.
50% trials, 50%
Service clinic
CPD/Admin
Ward Round
(Christie)
Leighton
8 am X.Ray
meet (alt wks)
MDT Christie
CPD/Admin
Wythenshaw
clinic (alt wks)
Weekly MDT and
2 clinics
13:00 to 17:00
Christie Clinic
1 pm seminar
3-5 pm with
MDT
The post holder will be expected to be on the Consultant on-call for Clinical or Medical
Oncology.
I)
Duties of the Post
1. Main Duties: To be a consultant at the Christie Hospital NHS Foundation Trust. This
will involve close liaison with other members of the multidisciplinary team. A major role of
this new post will be to develop and implement evidence based best practice for patients
treated at Christie, Leighton and SMUH Trust.
2. Clinical Management: To work closely with other medical colleagues in the fields of
colorectal cancer. An important role of the consultant will be to have direct involvement in
the day-to-day clinical management of patients. This post holder will create a close
interface between the laboratory and clinical medicine facilitating the continued
development of clinically relevant, evidence-based protocols.
3. Clinics: The post holder would be required support 4 clinics per week.
4. Protocols: The post holder will be expected to revise and develop evidence-based
protocols for patients. He/she will be expected to undertake the administrative duties
associated with the care of these patients.
5. Professional Development: He/she will maintain a level of continuing professional
development consistent with the recommendations of the Royal College of Physicians /
Radiologists. Appropriate arrangements for study leave will be made in conjunction with
colleagues. A fund, administered by the Clinical Director for the support of study leave,
exists within the Trust. The post-holder will also be required to undergo annual appraisal.
6. Teaching Commitment:
a) Undergraduate
The appointee will be required to contribute to the undergraduate teaching of medical
students on clinical topics. The undergraduate teaching commitment will amount at most
to the equivalent of around one session per week.
b) Postgraduate
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
9
The Unit has a busy postgraduate teaching programme and staff are often requested to
lecture on oncology topics. This may amount to one session per month.
7. Junior Doctor Training: The post holder will be expected to contribute actively to the
training of Specialty Trainees in oncology. The post holder will also be expected to help
in the training of nursing and multi-disciplinary staff in both in-patient and outpatient
departments.
8. Clinical Governance: The post-holder will be expected to participate in all relevant
aspects of clinical governance, including maintaining up to date protocols, guidelines and
clinical audit, under the supervision of the other consultants in the unit.
9. Audit: The appointee will play a full role in clinical audit as a member of the Christie
Hospital Medical Staff Committee.
10. Research: There are excellent opportunities for research within the department. The
appointee would be encouraged to contribute to current research projects within the
department and/or set up new projects.
11. On Call: The post attracts an on call commitment.
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
10
J)
PERSON SPECIFICATION
REQUIREMENTS
Qualifications
ESSENTIAL
 MBBS or equivalent
 MRCP or FRCR or equivalent
 Certificate of completion of subspecialty training in either Medical
Oncology or Clinical Oncology, or
evidence of completion within six
months of the date of the Advisory
Appointments Committee
DESIRABLE
Training & Experience
 Evidence of wide experience of
general and oncological medicine
 Evidence of extensive training in
the management of upper GI
cancers
 Demonstrated interest in teaching /
education
 An interest in teaching medical,
nursing and allied health
professional staff
 Experience of teaching
undergraduate / postgraduate
trainees
Academic / Research
achievements
 Able to demonstrate continuing
research interest and activity
 Recent articles in peer-reviewed
publications
 MSc, MD or PhD
 The ability to initiate design and
supervise clinical research
Personal Skills
 Clinical leadership and people
management skills, with the ability
to motivate staff
 Demonstrable interpersonal skills
 Evidence of excellent written and
oral communication skills
 Flexible approach to work
 The ability to work as part of as
multi-disciplinary team
 Good time management skills, with
the ability to handle competing
demands
Personal Circumstances
 Reliable work record
 Good health record
 Living within reasonable travelling
distance from the hospital
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
11
TERMS AND CONDITIONS OF SERVICE
PAY
The salary details for this post will be on the New Consultant Contract Payscale.
CONFIDENTIALITY
The post-holder must maintain the confidentiality of information about patients, staff and
other health service business.
HEALTH AND SAFETY
Employees must be aware of the responsibilities placed on them under the Health &
Safety at Work Act (1974), to ensure that the agreed safety procedures are carried out to
maintain a safe environment for employees.
RISK MANAGEMENT
All staff have a responsibility to report all clinical and non-clinical accidents or incidents
promptly and when requested to co-operate with any investigation undertaken.
EQUAL OPPORTUNITIES
The Trust has adopted an equal opportunities policy and it is the duty of every employee
to comply with the detail and spirit of the policy
CONFLICT OF INTEREST
The Trust is responsible for the service for the patients in its care meets the highest
standards. Equally, it is responsible for ensuring that staff do not abuse their official
position to gain or to benefit their family or friends.
The Trust’s standing orders require any officer to declare any interest, direct or indirect
with contracts involving the Trust. Staff are not allowed to further their private interest in
the course of their NHS duties.
NO SMOKING
The Trust operates a no smoking policy. Anyone who wishes to smoke may do so only
in one of the designated smoking areas at a time agreed with their line manager.
MEDICAL EXAMINATION
All appointments with Christie NHS Foundation Trust are subject to pre-employment
health screening.
K)
Informal Visits
Interested candidates are encouraged to discuss the post with one or more of the
following people.

Dr Michael Leahy, Clinical Director for Medical Oncology, may be contacted via his
secretary, Gwynneth Mattimore, on 0161 446 8384 or [email protected]

Dr Nick Slevin, 0161 446 3361 or [email protected]

Dr Mark Saunders, 0161 446 33357 or [email protected]

Dr Juan Valle, 0161 446 8106 or [email protected]
New Posts:
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
12
APPENDIX 1
Clinical Oncology Consultant Staff (July 2008)
Dr N J Slevin
Dr R A Cowan
Dr J P Logue
Dr P A Burt
Dr A Chittalia
Dr S E Davidson
Dr T Elliott
Dr C Faivre-Finn
Dr H R Gattamaneni
Dr M Harris
Prof T Illidge
Dr A Jackson
Dr L Lee
Dr E Levine
Dr JE Livsey
Dr J Loncaster
Dr L Pemberton
Dr B Magee
Dr V Misra
Dr C McBain
Prof P Price
Dr M Saunders
Dr E Smith
Dr A L Stewart Breast
Dr R Stout
Dr A Sykes
Dr R S Welch
Dr J Wylie
Dr B Yap
Dr E Allan
New Posts:
Head and Neck
Genito Urinary, Lymphoma
Genito Urinary
Lung
Breast, Lung
Gynaecology
Urology
Lung, oesophageal
Children/Young Adult/CNS
Lung/Lymphoma
Lymphoma
Upper GI
Head and neck, Lung
Gastro Intestinal
Gynaecology/urology
Breast, PDT for skin cancer
Lung
Breast cancer
Breast, Colorectal
Colorectal, CNS
Upper GI
Gastrointestinal
Lymphoma, Paediatric/Young Adult
Lung
Head & Neck/Melanoma
Ovarian Cancer, Testicularcancer, Breast cancer
Genito-urinary, Soft Tissue Sarcoma
Thyroid/Head & Neck
PDT for skin cancer
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
13
APPENDIX 2
Medical Oncology Consultant Staff (July 2008)
Prof R Hawkins
Prof A Howell
Prof G Jayson
Dr P Lorigan
Prof J Radford
Prof M Ranson
Prof N Thatcher
Dr F Blackhall
Dr J Valle
Dr A Wardley
Dr G Wilson
Dr J Hassan
Dr M Leahy
Dr W Mansoor
Dr S Mullamitha
Dr A Armstrong
Dr A Clamp
Dr F Thistlethwaite
New Posts:
Renal, Gastric and Immunotherapy Phase I Trials
Breast cancer prevention
Ovarian Cancer and Anti-Angiogenesis Phase I Trials
Melanoma and Lung Cancer
Lymphoma
Clinical Pharmacology and Lung Cancer
Lung Cancer
Lung Cancer
Colorectal, Pancreatic Cancer
Breast Cancer
Breast and Colorectal Cancer
Colorectal and Ovarian
Sarcoma and Teratoma
Upper GI and Carcinoid
Lower GI – link with Oldham
Breast Cancer
Ovarian and Gynaecological Oncology
Upper GI
job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008
14